Bioventus (BVS) Treasury Shares (2021 - 2026)

Bioventus (BVS) has 6 years of Treasury Shares data on file, last reported at $545000.0 in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 242.77% year-over-year to $545000.0; the trailing twelve-month figure through Mar 2026 stood at $545000.0 (up 242.77% YoY), and the FY2025 full-year result was $2.8 million, changed N/A from the prior year.
• Treasury Shares for Q1 2026 stood at $545000.0, down from $2.8 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.9 million in Q1 2024 and bottomed at $159000.0 in Q1 2025.
• The 5-year median for Treasury Shares is $1.7 million (2022), against an average of $1.8 million.
• The widest annual swing landed in 2022, when Treasury Shares soared 593.69%; it then plunged 95.96% in 2025.
• A 5-year view of Treasury Shares shows it stood at $1.2 million in 2022, then jumped by 73.76% to $2.1 million in 2023, then jumped by 35.53% to $2.8 million in 2024, then retreated by 0.82% to $2.8 million in 2025, then slumped by 80.37% to $545000.0 in 2026.
• The last three Treasury Shares figures came in at $545000.0 (Q1 2026), $2.8 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison